These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 17259674)

  • 1. Medical education and the pharmaceutical industry.
    Goodman RL
    Perspect Biol Med; 2007; 50(1):32-9. PubMed ID: 17259674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships?
    Carroll AE; Vreeman RC; Buddenbaum J; Inui TS
    Pediatrics; 2007 Dec; 120(6):e1528-35. PubMed ID: 18055668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
    Wofford JL; Ohl CA
    BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of educational interventions and medical school policies on medical students' attitudes toward pharmaceutical marketing practices: a multi-institutional study.
    Kao AC; Braddock C; Clay M; Elliott D; Epstein SK; Filstead W; Hotze T; May W; Reenan J
    Acad Med; 2011 Nov; 86(11):1454-62. PubMed ID: 21952057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.
    Chakrabarti A; Fleisher WP; Staley D; Calhoun L
    Ann R Coll Physicians Surg Can; 2002 Dec; 35(8 Suppl.):541-6. PubMed ID: 15015500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem.
    Brodkey AC
    Acad Psychiatry; 2005; 29(2):222-9. PubMed ID: 15937271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A national survey on the effect of pharmaceutical promotion on medical students.
    Vainiomäki M; Helve O; Vuorenkoski L
    Med Teach; 2004 Nov; 26(7):630-4. PubMed ID: 15763854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between pharmaceutical representatives and doctors in training. A thematic review.
    Zipkin DA; Steinman MA
    J Gen Intern Med; 2005 Aug; 20(8):777-86. PubMed ID: 16050893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes of preclinical and clinical medical students toward interactions with the pharmaceutical industry.
    Hyman PL; Hochman ME; Shaw JG; Steinman MA
    Acad Med; 2007 Jan; 82(1):94-9. PubMed ID: 17198299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Institutional leadership and faculty response: fostering professionalism at the University of Pennsylvania School of Medicine.
    Wasserstein AG; Brennan PJ; Rubenstein AH
    Acad Med; 2007 Nov; 82(11):1049-56. PubMed ID: 17971690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
    Misra S; Ganzini L; Keepers G
    Acad Psychiatry; 2010; 34(2):102-8. PubMed ID: 20224017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hidden curriculum: medical students' changing opinions toward the pharmaceutical industry.
    Fitz MM; Homan D; Reddy S; Griffith CH; Baker E; Simpson KP
    Acad Med; 2007 Oct; 82(10 Suppl):S1-3. PubMed ID: 17895670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing policies for the relationship between industry and clinicians: lessons learned from two academic health centers.
    Coleman DL
    Acad Med; 2008 Sep; 83(9):882-7. PubMed ID: 18728449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.
    CMAJ; 1993 Aug; 149(4):405-8. PubMed ID: 8348422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug representatives: giving you lunch or stealing your soul?
    Higgins SP
    Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical student exposure to and attitudes about pharmaceutical companies.
    Soyk C; Pfefferkorn B; McBride P; Rieselbach R
    WMJ; 2010 Jun; 109(3):142-8. PubMed ID: 20672554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
    Kerridge I; Maguire J; Newby D; McNeill PM; Henry D; Hill S; Day R; Macdonald G; Stokes B; Henderson K
    Intern Med J; 2005 Apr; 35(4):206-10. PubMed ID: 15836497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.